Michelle Ols
Impact in
- Rheumatology top 5%
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
- Immunology top 10%
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
Papers in
-
- Immunotherapy and Immune Responses 4
- Immune Response and Inflammation 3
- T-cell and B-cell Immunology 3
- Galectins and Cancer Biology 1
- Oncology 5
- CAR-T cell therapy research 4
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Mark J. Shlomchik (3 shared papers)Michael Kashgarian (1 shared paper)Lino L. Teichmann (1 shared paper)Boris Reizis (1 shared paper)Daniel H. Kaplan (1 shared paper)Felipe Andrade (1 shared paper)Herbert G. Bull (1 shared paper)Erika Darrah (1 shared paper)
- Journals
- Cancer Research (4 papers)Immunity (2 papers)Molecular Therapy (1 paper)Science Translational Medicine (1 paper)Annals of Oncology (1 paper)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Michelle Ols
11 papers receiving 366 citations
Peers
Comparison fields: 5 of 40
- Rheumatology 187
- Immunology 254
- Immunology and Allergy 24
- Radiology, Nuclear Medicine and Imaging 56
- Hematology 23
Countries citing papers authored by Michelle Ols
This map shows the geographic impact of Michelle Ols's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Ols with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Ols more than expected).
Fields of papers citing papers by Michelle Ols
This network shows the impact of papers produced by Michelle Ols. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Ols. The network helps show where Michelle Ols may publish in the future.
Co-authors
The 25 scholars most cited alongside Michelle Ols, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 143 | |
| 2 | 2013 | 135 | |
| 3 | 2011 | 55 | |
| 4 | 2016 | 25 | |
| 5 | 2025 | 4 | |
| 6 | 2023 | 4 | |
| 7 | 2025 | 2 | |
| 8 | 2024 | 2 | |
| 9 | 2021 | 1 | |
| 10 | 2024 | 1 | |
| 11 | 2022 | 1 |
About Michelle Ols
Michelle Ols is a scholar working on Immunology, Oncology, Molecular Biology, Biotechnology and Cardiology and Cardiovascular Medicine, having authored 11 papers that have together received 373 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), CAR-T cell therapy research (4 papers), Immune Response and Inflammation (3 papers), T-cell and B-cell Immunology (3 papers), Cancer Research and Treatments (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Galectins and Cancer Biology (1 paper) and Enzyme function and inhibition (1 paper). The work is most often cited by research in Rheumatology (187 citations), Immunology (254 citations), Immunology and Allergy (24 citations), Radiology, Nuclear Medicine and Imaging (56 citations) and Hematology (23 citations). Michelle Ols has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Mark J. Shlomchik, Michael Kashgarian, Lino L. Teichmann, Boris Reizis, Daniel H. Kaplan, Felipe Andrade, Herbert G. Bull, Erika Darrah, Jon T. Giles and Antony Rosen. Their work appears in journals such as Cancer Research, Immunity, Molecular Therapy, Science Translational Medicine and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.